Pharming Group NV (PHAR) — Defensive Interval Ratio
Pharming Group NV (PHAR) has a Defensive Interval Ratio of 578 days as of March 2026. Defensive assets of $177.83 Million (cash $-, short-term investments $117.80 Million, receivables $60.03 Million) cover 578 days of daily cash needs of $307.80K/day. Check PHAR goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Pharming Group NV Defensive Interval Ratio (2005–2025)
This chart shows how Pharming Group NV's Defensive Interval Ratio has evolved across 20 annual periods from 2005 to 2025. As of March 2026, the ratio stands at 578 days, meaning defensive assets of $177.83 Million can fund 578 days of operations without new revenue. Also explore Pharming Group NV annual equity growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Pharming Group NV (2005–2025)
The table below presents the year-by-year Defensive Interval Ratio for Pharming Group NV from 2005 to 2025, covering 20 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Pharming Group NV (PHAR) total market value.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 279 days | $88.47 Million | $317.24K/day | $- | $33.79 Million | ▼ -528 days |
| 2024 | 807 days | $163.12 Million | $202.20K/day | $- | $112.95 Million | ▼ -103 days |
| 2023 | 910 days | $194.30 Million | $213.61K/day | $- | $151.68 Million | ▲ +755 days |
| 2022 | 155 days | $25.33 Million | $163.56K/day | $- | $0.00 | ▼ -60 days |
| 2021 | 215 days | $27.59 Million | $128.14K/day | $- | $- | ▲ +104 days |
| 2020 | 112 days | $19.25 Million | $172.35K/day | $- | $- | ▲ +22 days |
| 2019 | 90 days | $28.20 Million | $313.02K/day | $- | $-661.91K | ▲ +19 days |
| 2018 | 71 days | $18.30 Million | $258.86K/day | $- | $- | ▲ +7 days |
| 2017 | 64 days | $12.22 Million | $192.37K/day | $- | $- | ▼ -17 days |
| 2016 | 81 days | $11.97 Million | $148.04K/day | $- | $- | ▼ 0 days |
| 2015 | 81 days | $3.27 Million | $40.36K/day | $- | $- | ▲ +46 days |
| 2014 | 35 days | $1.71 Million | $49.55K/day | $- | $- | ▲ +17 days |
| 2013 | 17 days | $849.24K | $48.90K/day | $- | $- | ▲ +1 days |
| 2012 | 17 days | $538.26K | $32.49K/day | $- | $- | ▼ -12 days |
| 2011 | 29 days | $830.24K | $28.89K/day | $- | $- | ▼ -64 days |
| 2010 | 93 days | $3.28 Million | $35.29K/day | $- | $- | ▲ +93 days |
| 2009 | 0 days | $0.00 | $142.37K/day | $- | $- | ▼ -109 days |
| 2008 | 109 days | $5.22 Million | $47.87K/day | $- | $5.22 Million | ▲ +109 days |
| 2006 | 0 days | $0.00 | $33.24K/day | $- | $- | ▼ -435 days |
| 2005 | 435 days | $8.05 Million | $18.52K/day | $- | $6.92 Million | — |